Skip to content
10-Q

Quarterly Report

VANSEN PHARMA INC.

0001477932-13-005936

← back to feed
Filed
Dec 4, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Dec 4, 2013 85.8M sh
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$332.42K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$332.42K
Long Term Debt Q3 2013 · Sep 30, 2013 $202.75K
Short Term Debt Q3 2013 · Sep 30, 2013 $873.62K
Stockholders Equity Q3 2013 · Sep 30, 2013 $1.98M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$104.46K
Current Liabilities Q3 2013 · Sep 30, 2013 $4.98M
Current Liabilities Q3 2013 · Dec 31, 2012 $119.48K
Total Liabilities Q3 2013 · Sep 30, 2013 $5.18M
Total Liabilities Q3 2013 · Dec 31, 2012 $119.48K
Current Assets Q3 2013 · Sep 30, 2013 $3.06M
Current Assets Q3 2013 · Dec 31, 2012 $15.02K
Total Assets Q3 2013 · Sep 30, 2013 $7.16M
Total Assets Q3 2013 · Dec 31, 2012 $15.02K
Sga Expense Q3 2013 · Sep 30, 2013 $1.01M
Sga Expense Q3 2013 · Sep 30, 2013 $1.01M
Sga Expense Q3 2013 · Sep 30, 2013 $1.01M
Operating Income Q3 2013 · Sep 30, 2013 −$1.59M
Operating Income Q3 2013 · Sep 30, 2013 −$1.59M
Operating Income Q3 2013 · Sep 30, 2013 −$1.59M
Gross Profit Q3 2013 · Sep 30, 2013 $281.38K
Gross Profit Q3 2013 · Sep 30, 2013 $281.38K
Gross Profit Q3 2013 · Sep 30, 2013 $281.38K
Cost Of Revenue Q3 2013 · Sep 30, 2013 $400.92K
Cost Of Revenue Q3 2013 · Sep 30, 2013 $400.92K
Cost Of Revenue Q3 2013 · Sep 30, 2013 $400.92K
Revenue Q3 2013 · Sep 30, 2013 $682.3K
Revenue Q3 2013 · Sep 30, 2013 $682.3K
Revenue Q3 2013 · Sep 30, 2013 $682.3K